close
Add to watchlist
Cyberonics Inc (CYBX) Healthcare, Medical Equipment & Supplies
Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression. Its VNS therapy system consists of a pulse generator to provide the stimulation to the vagus nerve; a bipolar lead; a tunneling tool to assist with implantation surgery; a programming wand and software for setting the stimulation parameters after implantation of the generator and lead; magnets to suspend or induce stimulation manually; and instruction manuals. The company sells its products for refractory epilepsy through direct sales and marketing forces in Austria, Belgium, Denmark, France, Germany, Luxemburg, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom, as well as through distribution agreements with independent distributors of various territories, including Canada, Mexico, Australia, parts of Central and South America, Asia, the Middle East, and Europe. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 38.62 |
| Volume | 130376 |
| Volume Avg | 226554 |
| 52 Week High | 39.18 |
| 52 Week Low | 26.19 |
| PE | 33.39 |
| PE (group average) | 39 |
| EPS Year | 1.16 |
| EPS change Q/Q | -70.79% |
| EPS change Q/Q Yr ago | -18.75% |
| EPS change Q/Q next Q est | -27.78% |
| EPS change Y/Y | 45.36% |
| REV change Q/Q | -0.84% |
| REV change Q/Q Yr ago | 15.44% |
| EPS next Q est | 0.36 |
| EPS next Y est | 1.54 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |